3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
申请人:——
公开号:US20040077643A1
公开(公告)日:2004-04-22
A 3,4-dihydroisoquinoline derivative compound of formula (I) or a non-toxic salt thereof and a pharmaceutical agent comprising it as active ingredient (wherein all symbols have the same meaning as described in the specification). The compound of formula (I) has agonizing activity on CB2 receptor and therefore it is useful for the prophilaxis and/or treatment of various diseases such as asthma, nasal allergy, atopic dermatitis, autoimmune diseases, rheumatoid arthritis, immune dysfunction, postoperative pain, carcinomatous pain, etc.
1
公式(I)的3,4-二氢异喹啉衍生物化合物或其无毒盐,以及包含其作为活性成分的药物剂。公式(I)的化合物对CB2受体具有激动活性,因此对于预防和/或治疗哮喘、鼻过敏、特应性皮炎、自身免疫疾病、类风湿关节炎、免疫功能障碍、术后疼痛、癌症性疼痛等多种疾病是有用的。